Saturday, 31 October 2026 AboutContactRSS
Financial news from India and the world, in two minutes.
Nifty 50 23,053.10 ▲ +116.35 (+0.51%)
Bank Nifty 54,686.95 ▼ -222.70 (-0.41%)
Nifty Next 50 67,709.10 ▼ -412.50 (-0.61%)
Nifty Midcap 100 57,301.25 ▼ -540.40 (-0.93%)
Nifty IT 32,606.90 ▲ +740.50 (+2.32%)
NSE · 30 Oct, 3:30 pm IST

Home › Results › India

Sun Pharma Q2 profit falls 36% to Rs 1,989 crore on one-time charges

Sun Pharma Q2 results: net profit fell 36% to Rs 1,989 crore on one-time charges, while revenue rose about 12% to Rs 16,199 crore.

Tablets and capsules in blister packs and a glass jar
Representative image. Tablets and capsules in blister packs and a glass jar Photo: BuhaM / Wikimedia Commons, CC BY-SA 4.0

Sun Pharma Q2 results showed a 36% year-on-year fall in net profit to Rs 1,989 crore for the September quarter of FY27. The decline at Sun Pharmaceutical Industries was driven by exceptional items, including litigation costs and expenses linked to acquisitions, rather than weaker sales.

Sun Pharma Q2 results by market

Revenue from operations rose about 12% (11.8%) to Rs 16,199 crore from Rs 14,478 crore a year earlier. Growth was led by the company’s domestic formulations business in India and by emerging markets. Sales of formulations in the US, however, declined during the quarter.

The company also said it is moving ahead with integration planning for its acquisition of Organon now that the required regulatory approvals have been received.

Despite the drop in profit, Sun Pharma shares rose after the results, according to reports, as investors focused on revenue growth and treated the hit to earnings as one-time.

Key numbers

  • Net profit: Rs 1,989 crore (−36% YoY)
  • Revenue from operations: Rs 16,199 crore (+11.8% YoY)
  • Year-ago revenue: Rs 14,478 crore

Read more quarterly results news on ArthaWire.

Frequently asked questions

What were Sun Pharma's Q2 FY27 results?

Net profit fell 36% to Rs 1,989 crore due to one-time charges, while revenue from operations rose 11.8% to Rs 16,199 crore.

Why did Sun Pharma's profit fall in Q2?

Exceptional items, including litigation costs and acquisition-related expenses, hit earnings.

sun pharmapharmaorganonq2fy27

This article is a summary for information only and is not investment advice. Figures are as reported by the sources above; please verify with the original filing or report before making any decision.

More Results News

See all →